Last reviewed · How we verify

NCT06159764: CANVAS-R

National Registry of Cardioneuroablation in Recurrent Reflex Syncope

Recruiting now Last updated 17 June 2025
What this trial tests

trial testing Cardioneuroablation in Syncope, Vasovagal in 50 participants. Currently enrolling.

Timeline
27 November 2024
Primary endpoint
31 January 2026
31 January 2026

Quick facts

Lead sponsorUniversity Hospital, Bordeaux
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date27 November 2024
Primary completion31 January 2026
Estimated completion31 January 2026
Sites14 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Bordeaux

Who can join

Adults 18 to 100, any sex, with Syncope, Vasovagal or Bradycardia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This registry aims to collect patient data on cardioneuroablation for vasovagal syncope from multiple centers in France. The aim is to evaluate success rates, compare techniques and help institutions set up their own cardioneuroablation program

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Cardioneuroablation

Trials testing the same drug.

Other recruiting trials for Syncope, Vasovagal

Currently open trials in the same condition.

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06159764.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing